Jefferies Group CTMX Holdings History
Jefferies Group's CytomX Therapeutics Inc Holding Summary
As of 2026-03-31, Leucadia National held 3.07 Mil shares of CytomX Therapeutics Inc(CTMX), totaling $14.42 Mil. This investment constitutes 0.1% of their stock portfolio, and Leucadia National now holds 1.41% of the outstanding CytomX Therapeutics Inc(CTMX) stock.
The initial trade took place in 2025Q3. And since then Jefferies Group has made 2 purchases of CTMX, at an average price of $5.03, for a total of 3.10 Mil shares. In addition, there have been 1 sales at an average price of $3.81 for 29,150.00 shares. Based on historical transaction data and CTMX's current price of $3.55, Jefferies Group's estimated gain on his CTMX holdings is $-4.60 Mil, reflecting a -29.50% gain to date.
Jefferies Group CTMX ($3.55) Holding Chart
Jefferies Group CTMX ($3.55) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Articles on CytomX Therapeutics Inc
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
